EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of Bone Marrow Biopsy and Flow Cytometry in Demonstrating Bone Marrow Metastasis of Neuroblastoma

Esra Arslantaş iD, Ali Ayçiçek, Selvinaz Özkara, Ayşe Özkan Karagenç, Sibel Akpınar Tekgündüz, Duygu Yıldırgan, Tuba Nur Tahtakesen Güçer, Ayşe Gonca Kaçar, Özgü Hançerli iD, Saide Ertürk, Ezgi Paslı Uysalol iD, Cengiz Bayram

Diagnostics · 11.12.2024 · 14 (24) · 2776

DOI: 10.3390/diagnostics14242776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 11.12.2024. Verfasst von Esra Arslantaş und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to compare bone marrow aspirate (BMA) multicolor flow cytometry (MFC) analysis and bone marrow biopsy (BMB) in detecting bone marrow (BM) involvement in children with neuroblastoma (NB) at diagnosis and during follow-up. Materials and Methods: A total of 132 BM samples from 39 patients (M/F ratio: 19/20; median age: 38 months) with neuroblastoma were simultaneously obtained for evaluation. The samples were investigated for BM involvement using BMB and MFC.

Results

A comparison between MFC (n: 60) and BMB (n: 60) was possible for 120 samples. When BMB was considered as the reference standard, MFC had diagnostic sensitivity, specificity, positive predictive value, and negative predictive value of 86%, 58%, 54%, and 88%, respectively, and values of 90%, 57%, 60%, and 89%, respectively, at diagnosis. The median proportion of CD45−/CD56+ cells in MFC was 0.028% (range 0–35%). The event-free survival (EFS) rates for MFC (+) and MFC (−) patients according to the analysis results of the BM samples at the time of diagnosis were 70.6% and 81.8%, respectively (p = 0.607), and the overall survival (OS) rates were 88.2% in MFC (+) patients and 90.9% in MFC (−) patients (p = 0.583).

Conclusion

Multicolor flow cytometry may be used as an adjunct to cytomorphology to achieve more sensitive and accurate results as an objective, quantitative method with fast results in detecting bone marrow involvement in children with NB.

Schlagwörter

Stichwörter der Autor:innen

bone marrowbone marrow biopsychildrenflow cytometrymetastasisneuroblastoma

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey.
  • Department of Pathology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey.

ORCID-Profile: Esra Arslantaş, Özgü Hançerli, Ezgi Paslı Uysalol

Zitieren

APA

Arslantaş, E., Ayçiçek, A., Özkara, S., Özkan Karagenç, A., Tekgündüz, S. A., Yıldırgan, D., Tahtakesen Güçer, T. N., Kaçar, A. G., Hançerli, Ö., Ertürk, S., Paslı Uysalol, E., & Bayram, C. (2024). Comparison of Bone Marrow Biopsy and Flow Cytometry in Demonstrating Bone Marrow Metastasis of Neuroblastoma. Diagnostics, 14(24), 2776. https://doi.org/10.3390/diagnostics14242776

Vancouver

Arslantaş E, Ayçiçek A, Özkara S, Özkan Karagenç A, Tekgündüz SA, Yıldırgan D, et al. Comparison of Bone Marrow Biopsy and Flow Cytometry in Demonstrating Bone Marrow Metastasis of Neuroblastoma. Diagnostics. 2024;14(24):2776. doi:10.3390/diagnostics14242776

BibTeX
@article{Arslanta2024,
  author = {Arslantaş, Esra and Ayçiçek, Ali and Özkara, Selvinaz and Özkan Karagenç, Ayşe and Tekgündüz, Sibel Akpınar and Yıldırgan, Duygu and Tahtakesen Güçer, Tuba Nur and Kaçar, Ayşe Gonca and Hançerli, Özgü and Ertürk, Saide and Paslı Uysalol, Ezgi and Bayram, Cengiz},
  title = {Comparison of Bone Marrow Biopsy and Flow Cytometry in Demonstrating Bone Marrow Metastasis of Neuroblastoma},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {24},
  pages = {2776},
  doi = {10.3390/diagnostics14242776}
}
Kostenlos starten →